0,833  0,002  Antiparkinsonian, rigidity relieving
0,649  0,014  Respiratory analeptic
0,628  0,004  Muscle relaxant
0,586  0,004  Skeletal muscle relaxant
0,595  0,015  5 Hydroxytryptamine release stimulant
0,566  0,005  Male reproductive disfunction treatment
0,563  0,003  Dopamine D2 agonist
0,564  0,009  CYP2D6 inhibitor
0,552  0,005  Sigma receptor agonist
0,547  0,004  Dopamine agonist
0,548  0,004  Erectile dysfunction treatment
0,552  0,044  Caspase 9 stimulant
0,496  0,023  Analeptic
0,470  0,005  5 Hydroxytryptamine 7 antagonist
0,468  0,033  Antidepressant
0,477  0,046  Antiparkinsonian
0,464  0,037  Mood disorders treatment
0,498  0,075  Apoptosis agonist
0,425  0,006  5 Hydroxytryptamine 2A antagonist
0,402  0,010  5 Hydroxytryptamine 2 antagonist
0,433  0,045  Prostate cancer treatment
0,401  0,020  Antineoplastic enhancer
0,418  0,039  Caspase 3 stimulant
0,386  0,008  Dopamine antagonist
0,425  0,058  Transcription factor NF kappa B inhibitor
0,369  0,005  Alpha 2 adrenoreceptor antagonist
0,382  0,029  Cardiodepressant
0,416  0,067  Histamine release inhibitor
0,394  0,046  Hepatic disorders treatment
0,356  0,012  Alpha adrenoreceptor antagonist
0,346  0,006  Alpha 2b adrenoreceptor antagonist
0,348  0,016  Tyrosine 3 hydroxylase inhibitor
0,339  0,010  Neurotrophic factor enhancer
0,336  0,009  Dopamine D2 antagonist
0,371  0,047  Spasmolytic
0,323  0,016  5 Hydroxytryptamine antagonist
0,303  0,005  Dopamine D1 antagonist
0,334  0,038  Vasodilator
0,304  0,016  Antiparkinsonian, tremor relieving
0,289  0,004  Dopamine D5 antagonist
0,300  0,017  Liver fibrosis treatment
0,332  0,051  Hypoxia-inducible factor 1 alpha inhibitor
0,360  0,085  CYP2C19 inhibitor
0,339  0,065  Antihypertensive
0,329  0,061  Antipsychotic
0,264  0,004  Antineoplastic alkaloid
0,282  0,025  Antineoplastic (squamous cell carcinoma)
0,260  0,009  Alpha 2c adrenoreceptor antagonist
0,335  0,084  CYP3A4 substrate
0,317  0,068  CYP3A4 inhibitor
0,258  0,012  5 Hydroxytryptamine 1 antagonist
0,249  0,006  Female sexual dysfunction treatment
0,342  0,104  15-Lipoxygenase inhibitor
0,285  0,048  Cyclic AMP phosphodiesterase inhibitor
0,281  0,044  5 Hydroxytryptamine 1E antagonist
0,257  0,023  Topoisomerase II inhibitor
0,248  0,017  Topoisomerase I inhibitor
0,306  0,076  Antineoplastic (brain cancer)
0,278  0,049  Psychostimulant
0,240  0,012  5 Hydroxytryptamine 1A antagonist
0,218  0,005  Antiviral (Papilloma)
0,222  0,009  Dopamine D3 antagonist
0,223  0,011  Alpha 2a adrenoreceptor antagonist
0,307  0,096  Antineoplastic (lung cancer)
0,230  0,021  Antiviral (Hepatitis B)
0,307  0,099  Antileukemic
0,236  0,031  Antiischemic, cerebral
0,232  0,026  5 Hydroxytryptamine 3E antagonist
0,249  0,044  Hepatoprotectant
0,230  0,031  Acetylcholine M1 receptor antagonist
0,240  0,044  P-glycoprotein inhibitor
0,296  0,109  Cognition disorders treatment
0,214  0,029  Uterine stimulant
0,188  0,005  Phosphodiesterase 11A inhibitor
0,188  0,005  Phosphodiesterase XI inhibitor
0,236  0,053  Abortion inducer
0,211  0,028  Acetylcholine antagonist
0,211  0,029  Cholinergic antagonist
0,186  0,005  Restless leg syndrome treatment
0,187  0,007  Phosphodiesterase V inhibitor
0,193  0,014  Breast cancer-resistant protein inhibitor
0,213  0,035  Toxic, respiratory center
0,202  0,024  Antiadrenergic
0,241  0,063  Dependence treatment
0,221  0,057  Pneumotoxic
0,206  0,044  Cholinergic
0,231  0,068  Antimitotic
0,188  0,026  Adrenaline antagonist
0,173  0,012  CDC-like kinase 3 inhibitor
0,168  0,009  Phosphodiesterase 5A inhibitor
0,187  0,028  Acetylcholine muscarinic antagonist
0,220  0,062  Sedative
0,194  0,039  CDC-like kinase 1 inhibitor
0,168  0,014  Opioid kappa receptor antagonist
0,178  0,024  Alpha 1 adrenoreceptor antagonist
0,164  0,019  5 Hydroxytryptamine agonist
0,177  0,033  DNA intercalator
0,227  0,086  Antineoplastic (liver cancer)
0,199  0,060  Antiviral (Hepatitis)
0,171  0,034  Antitussive
0,156  0,021  Calcium antagonist
0,265  0,132  Stroke treatment
0,239  0,109  CYP1A2 substrate
0,213  0,084  Antineoplastic (lymphoma)
0,258  0,128  Antineoplastic (small cell lung cancer)
0,225  0,096  DNA damaging
0,202  0,073  Anesthetic general
0,191  0,063  LDLR expression enhancer
0,236  0,111  Anxiolytic
0,204  0,082  Antialcoholic
0,130  0,010  5 Hydroxytryptamine 5A antagonist
0,240  0,121  Bone diseases treatment
0,200  0,083  Anticonvulsant
0,169  0,053  Genotoxic
0,223  0,108  Antineoplastic (colon cancer)
0,229  0,114  Antineoplastic (colorectal cancer)
0,200  0,085  Antineoplastic (glioblastoma multiforme)
0,230  0,118  CYP2D6 substrate
0,256  0,144  CYP2C9 substrate
0,118  0,008  Opioid kappa receptor agonist
0,209  0,100  Antihypercholesterolemic
0,149  0,041  5 Hydroxytryptamine 2B antagonist
0,137  0,030  Opioid antagonist
0,133  0,026  Alpha 1a adrenoreceptor antagonist
0,156  0,052  Acetylcholinesterase inhibitor
0,114  0,013  5 Hydroxytryptamine 5 antagonist
0,163  0,065  Carcinogenic, group 1
0,114  0,018  Antiviral (Hepatitis A)
0,159  0,063  Antineoplastic (carcinoma)
0,117  0,022  Dopamine D4 antagonist
0,099  0,005  Prolactin release inhibitor
0,113  0,022  Nicotinic alpha4beta2 receptor antagonist
0,125  0,035  Prolactin inhibitor
0,192  0,104  Antineoplastic (glioma)
0,179  0,094  VEGF expression inhibitor
0,112  0,027  Opioid mu receptor antagonist
0,103  0,022  5 Hydroxytryptamine 1B antagonist
0,113  0,033  Acetylcholine nicotinic antagonist
0,222  0,143  Prostaglandin dehydrogenase inhibitor
0,092  0,015  Opioid agonist
0,100  0,031  Analgesic, opioid
0,095  0,026  Premenstrual syndrome treatment
0,230  0,161  Antineoplastic (breast cancer)
0,138  0,069  Psychosexual dysfunction treatment
0,071  0,004  Dopamine D1 agonist
0,165  0,100  Antiarrhythmic
0,090  0,026  Alpha 1d adrenoreceptor antagonist
0,205  0,141  5 Hydroxytryptamine uptake stimulant
0,128  0,064  Papain-like protease (SARS coronavirus) inhibitor
0,098  0,035  mTOR complex 2 inhibitor
0,101  0,038  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,083  0,022  Alpha 2 adrenoreceptor agonist
0,121  0,060  Constipation treatment
0,094  0,033  Acetylcholine M4 receptor antagonist
0,159  0,098  Antineoplastic (bone cancer)
0,124  0,064  Alkylator
0,130  0,071  Tubulin antagonist
0,075  0,017  5 Hydroxytryptamine 2 agonist
0,182  0,125  Antineoplastic (renal cancer)
0,092  0,035  5 Hydroxytryptamine 1F antagonist
0,068  0,012  Factor III inhibitor
0,095  0,041  Acetylcholine nicotinic agonist
0,085  0,032  Neuronal nicotinic receptor antagonist
0,081  0,029  Acetylcholine M2 receptor antagonist
0,095  0,043  Topoisomerase II alpha inhibitor
0,130  0,080  Neurotrophic factor
0,059  0,009  Phosphodiesterase 6C inhibitor
0,053  0,004  HCV NS5A inhibitor
0,071  0,022  5 Hydroxytryptamine 1A agonist
0,069  0,020  Opioid mu receptor agonist
0,165  0,117  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,067  0,020  Nicotinic alpha3beta2 receptor antagonist
0,060  0,014  Kinesin-like protein 1 inhibitor
0,060  0,014  Kinesin antagonist
0,155  0,111  Pyruvate kinase inhibitor
0,065  0,021  5 Hydroxytryptamine 1B agonist
0,082  0,038  MAP3K7 inhibitor
0,078  0,037  Opioid delta receptor antagonist
0,173  0,132  Tumour necrosis factor alpha release inhibitor
0,264  0,224  Antineoplastic (solid tumors)
0,046  0,008  Carnitine palmitoyltransferase 1A inhibitor
0,091  0,054  ATPase (Vacuolar H+) inhibitor
0,060  0,024  5 Hydroxytryptamine 4 antagonist
0,063  0,026  5 Hydroxytryptamine 7 agonist
0,059  0,022  5 Hydroxytryptamine 2C agonist
0,077  0,041  Potassium channel (Tandem pore domain) blocker
0,042  0,009  Dopamine autoreceptor agonist
0,050  0,017  Plasmepsin II inhibitor
0,112  0,080  Antiseptic
0,175  0,145  Antineoplastic (ovarian cancer)
0,101  0,072  Choleretic
0,112  0,083  Antiprotozoal (Amoeba)
0,039  0,012  Phosphodiesterase 6B inhibitor
0,058  0,031  Nicotinic receptor alpha7 subunit antagonist
0,062  0,036  Dopamine uptake inhibitor
0,201  0,175  Vasodilator, peripheral
0,075  0,049  Alpha 1b adrenoreceptor antagonist
0,086  0,062  Tocolytic
0,070  0,046  Alpha adrenoreceptor agonist
0,116  0,094  Antifungal enhancer
0,112  0,090  Antismoking
0,071  0,051  Calcium channel L-type blocker
0,055  0,035  5 Hydroxytryptamine 1 agonist
0,050  0,031  AMPA receptor antagonist
0,028  0,010  Phosphodiesterase 6H inhibitor
0,028  0,010  Phosphodiesterase 6G inhibitor
0,169  0,152  Cardiotonic
0,050  0,034  Sigma receptor antagonist
0,105  0,089  Sphingosine 1-phosphate receptor 2 agonist
0,038  0,022  5 Hydroxytryptamine 3B antagonist
0,054  0,038  Nicotinic alpha7 receptor agonist
0,093  0,077  Expectorant
0,168  0,153  Antineoplastic (melanoma)
0,055  0,040  Nicotinic neuronal receptor agonist
0,056  0,042  Alpha 1 adrenoreceptor agonist
0,150  0,136  Dyrk kinase inhibitor
0,090  0,076  Phosphodiesterase 6D inhibitor
0,030  0,018  Endothelin receptor antagonist
0,125  0,113  Irritable Bowel syndrome treatment
0,153  0,142  NOS2 expression inhibitor
0,121  0,110  Urinary incontinence treatment
0,127  0,117  Pulmonary hypertension treatment
0,057  0,048  Ryanodine receptor antagonist
0,045  0,037  Baculoviral IAP repeat-containing protein inhibitor
0,042  0,035  Poly(ADP-ribose) polymerase inhibitor
0,019  0,013  Endothelin B receptor antagonist
0,104  0,098  Cyclooxygenase 3 inhibitor
0,056  0,051  5 Hydroxytryptamine 2A agonist
0,072  0,066  Antitreponemal
0,114  0,109  Mutagenic
0,046  0,043  Prolyl endopeptidase inhibitor
0,217  0,216  Analgesic
0,052  0,052  Acetylcholine M3 receptor antagonist
0,092  0,091  Anesthetic local
0,018  0,018  Endothelin A receptor antagonist

